Literature DB >> 6182911

Implications for clinical application of new developments in interferon research.

J Taylor-Papadimitriou, F R Balkwill.   

Abstract

Mesh：

Substances：

Year:  1982        PMID： 6182911     DOI： 10.1016/0304-419x(82)90006-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN： 0006-3002


× No keyword cloud information.
  8 in total

1.  Interferon-gamma and cytotoxic agents studied in combination using a soft agarose human tumor clonogenic assay.

Authors:  T Saito; M E Berens; C E Welander
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

2.  Cyclic AMP mediates the direct antiproliferative action of mismatched double-stranded RNA.

Authors:  H R Hubbell; J E Boyer; P Roane; R M Burch
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

3.  Interferon-beta can induce the production of plasminogen activator by cultured human cancer cells.

Authors:  M Karai; M Namba
Journal:  Experientia       Date:  1987-04-15

4.  Sensitivities of human glioma cell lines to interferons and double-stranded RNAs individually and in synergistic combinations.

Authors:  R S Dick; H R Hubbell
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

5.  Chemical synthesis of a human interferon-alpha 2 gene and its expression in Escherichia coli.

Authors:  M D Edge; A R Greene; G R Heathcliffe; V E Moore; N J Faulkner; R Camble; N N Petter; P Trueman; W Schuch; J Hennam
Journal:  Nucleic Acids Res       Date:  1983-09-24       Impact factor: 16.971

6.  In vitro chemosensitivity tests on human tumor xenografts by clonogenic assay: the combined use of mitomycin C with alpha-interferon or gamma-interferon.

Authors:  N Hirabayashi; K Yoshinaka; Y Nosoh; T Toge; M Niimoto; T Hattori; T Ohkita
Journal:  Jpn J Surg       Date:  1985-07

7.  Positive interactions between human interferon and cepharanthin against human cancer cells in vitro and in vivo.

Authors:  M Ono; N Tanaka; K Orita
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

8.  Interferon therapy and immunity.

Authors:  D F Woodrow
Journal:  J R Soc Med       Date:  1983-03       Impact factor: 18.000
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.